Pascal Deschatelets Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 18 hours ago
Pascal Deschatelets has an estimated net worth of at least $59.7 million*, as of Jan. 22, 2025. They own 1.1 million shares of APLS stock. They have sold 457,924 shares of APLS stock since 2021, for an estimated $25.0 million.
Pascal Deschatelets $APLS SEC Form 4 Insider Trading
Pascal Deschatelets has filed a total of 35 insider trades in $APLS since 2021. Their most recent trade was a sale of 3,948 shares, made on Jan 22, 2025. Their largest trade was a sale of 64,379 shares, made on Apr 08, 2024. We estimate that they now own 1.1 million shares of $APLS, worth an estimated $34.8 million.
Insider Trading at $APLS
There have been a total of 279 insider trades reported at $APLS since 2021, with 250,000 shares purchased and 2.0 million shares sold. The most active insider traders in $APLS stock have been Pascal Deschatelets, Cedric Francois, and Adam J. Townsend. The most recent trade was a sale of 3,323 shares reported by David O. Watson (General Counsel), made on Jan 22, 2025.
History of Insider Stock Trades by Pascal Deschatelets
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
APLS | Sale | 3,948 | Jan 22, 2025 | Jan. 23, 2025, 4:25 p.m. |
APLS | Sale | 750 | Jan 17, 2025 | Jan. 21, 2025, 5:02 p.m. |
APLS | Sale | 2,288 | Jan 13, 2025 | Jan. 14, 2025, 5:14 p.m. |
APLS | Sale | 100 | May 08, 2024 | May 9, 2024, 5:15 p.m. |
APLS | Sale | 56,335 | May 08, 2024 | May 9, 2024, 5:15 p.m. |
APLS | Sale | 22,472 | May 08, 2024 | May 9, 2024, 5:15 p.m. |
APLS | Sale | 4,728 | Apr 08, 2024 | April 9, 2024, 4:25 p.m. |
APLS | Sale | 64,379 | Apr 08, 2024 | April 9, 2024, 4:25 p.m. |
APLS | Sale | 100 | Mar 08, 2024 | March 11, 2024, 4:08 p.m. |
APLS | Sale | 42,750 | Mar 08, 2024 | March 11, 2024, 4:08 p.m. |
APLS | Sale | 26,257 | Mar 08, 2024 | March 11, 2024, 4:08 p.m. |
APLS | Sale | 1,148 | Feb 12, 2024 | Feb. 13, 2024, 5:43 p.m. |
APLS | Sale | 874 | Jan 29, 2024 | Jan. 31, 2024, 5:21 p.m. |
APLS | Sale | 3,913 | Jan 22, 2024 | Jan. 23, 2024, 7:03 p.m. |
APLS | Sale | 1,632 | Jan 16, 2024 | Jan. 17, 2024, 5:47 p.m. |
APLS | Sale | 12,000 | Nov 08, 2023 | Nov. 9, 2023, 5:18 p.m. |
APLS | Sale | 12,000 | Oct 09, 2023 | Oct. 10, 2023, 4:26 p.m. |
APLS | Sale | 12,000 | Sep 08, 2023 | Sept. 11, 2023, 4:58 p.m. |
APLS | Sale | 12,000 | Aug 08, 2023 | Aug. 9, 2023, 4:08 p.m. |
APLS | Sale | 12,000 | Jul 10, 2023 | July 11, 2023, 5:37 p.m. |
APLS | Sale | 12,000 | Jun 08, 2023 | June 9, 2023, 4:40 p.m. |
APLS | Sale | 12,000 | May 08, 2023 | May 9, 2023, 5:02 p.m. |
APLS | Sale | 12,000 | Apr 10, 2023 | April 11, 2023, 4:20 p.m. |
APLS | Sale | 12,000 | Mar 08, 2023 | March 10, 2023, 6:18 p.m. |
APLS | Sale | 12,000 | Feb 08, 2023 | Feb. 10, 2023, 6 p.m. |
APLS | Sale | 12,000 | Jan 09, 2023 | Jan. 10, 2023, 9:07 p.m. |
APLS | Sale | 12,000 | Dec 08, 2022 | Dec. 12, 2022, 5:28 p.m. |
APLS | Sale | 12,000 | Nov 08, 2022 | Nov. 10, 2022, 9:30 a.m. |
APLS | Sale | 12,000 | Oct 10, 2022 | Oct. 11, 2022, 4:58 p.m. |
APLS | Sale | 12,000 | Sep 08, 2022 | Sept. 12, 2022, 4:52 p.m. |
APLS | Sale | 12,000 | Aug 08, 2022 | Aug. 9, 2022, 1:18 p.m. |
APLS | Sale | 12,000 | Jul 08, 2022 | July 12, 2022, 4:04 p.m. |
APLS | Sale | 12,000 | Jun 08, 2022 | June 9, 2022, 5:23 p.m. |
APLS | Sale | 4,000 | Apr 29, 2022 | May 2, 2022, 8:05 p.m. |
APLS | Sale | 6,250 | Jun 24, 2021 | June 24, 2021, 8 p.m. |
$APLS Executives and Stock Owners with Insider Trades
-
Pascal Deschatelets, Chief Scientific Officer
-
Cedric Francois, Chief Executive Officer
-
Adam J. Townsend, Chief Commercial Officer
-
Federico Grossi, CHIEF MEDICAL OFFICER
-
David O. Watson, General Counsel
-
Timothy Eugene Sullivan, Chief Financial Officer
-
Jeffrey Eisele, Chief Development Officer
-
Karen Lewis, Chief People Officer
-
Mark Jeffrey Delong, Senior Vice President
-
Lukas Scheibler, CHIEF INNOVATION OFFICER
-
Nur Nicholson, Chief Technical Officer
-
James George Chopas, VP/Chief Accounting Officer
-
Mark Jeffrey Delong, Chief Business & Strat Officer
-
Nicole D Perry, Vice President - Accounting
-
Caroline Baumal, Chief Medical Officer
-
Federico Grossi, Chief Medical Officer
-
Lukas Scheibler, Chief Research Officer
-
Victoria L. Brown, Program Team Lead
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.